Long-term follow-up in high risk hypertensive patients with carotid dolicoarteriopathies

Antonio Valvano1, Giorgio Bosso1, Valentina Apuzzi1

  • 1Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Insights

Carotid dolicoarteriopathies (CDA) are common but do not increase the risk of cerebrovascular events like stroke or TIA in hypertensive patients. This study found no significant association between CDA and major cerebral events in high-risk individuals.

Area of Science:

  • Vascular Neurology
  • Cerebrovascular Diseases
  • Medical Imaging

Background:

  • Carotid dolicoarteriopathies (CDA) are frequently observed but their link to cerebrovascular diseases remains uncertain.
  • Understanding the clinical significance of CDA is crucial for managing patients at risk.

Purpose of the Study:

  • To investigate the potential relationship between carotid dolicoarteriopathies and the incidence of cerebrovascular events.
  • To clarify if CDA is an independent risk factor for stroke or transient ischemic attack.

Main Methods:

  • Retrospective analysis of 2124 hypertensive patients with high cardiovascular risk.
  • Carotid ultrasound performed between January 2000 and December 2008.
  • 10-year follow-up data collected on cerebrovascular events (stroke and TIA).

Main Results:

  • Prevalence of CDA was 12.9% (274/2124), with higher frequency in females and left carotid artery.
  • Cerebrovascular event rates were similar in patients with and without CDA (10.94% vs. 10.97%).
  • No significant differences observed in stroke (8.39% vs. 8.38%) or TIA (2.55% vs. 2.59%) rates.

Conclusions:

  • Carotid dolicoarteriopathies are not associated with an increased occurrence of cerebrovascular events.
  • CDA does not appear to be a significant risk factor for stroke or TIA in this high-risk hypertensive population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
196
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
407
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
403
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
221
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
296